<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001803150</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001776985</issuerCik>
      <issuerName>BioNTech SE</issuerName>
      <secFileNumber>001-39081</secFileNumber>
      <issuerAddress>
        <com:street1>AN DER GOLDGRUBE 12</com:street1>
        <com:city>MAINZ</com:city>
        <com:stateOrCountry>2M</com:stateOrCountry>
        <com:zipCode>55131</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>0049613190840</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Medine GmbH</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>American Depositary Shares representing ordinary shares, no par value per share</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Berenberg Capital Markets LLC</name>
        <address>
          <com:street1>1251 Avenue of the Americas</com:street1>
          <com:street2>53rd Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10020</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>858209</noOfUnitsSold>
      <aggregateMarketValue>80379854.94</aggregateMarketValue>
      <noOfUnitsOutstanding>252884261</noOfUnitsOutstanding>
      <approxSaleDate>05/13/2026</approxSaleDate>
      <securitiesExchangeName>Nasdaq Global Select</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares, no par value per share</securitiesClassTitle>
      <acquiredDate>11/21/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>BioNTech SE</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>856186</amountOfSecuritiesAcquired>
      <paymentDate>11/21/2022</paymentDate>
      <natureOfPayment>Stock Option Exercise</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares, no par value per share</securitiesClassTitle>
      <acquiredDate>08/09/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>BioNTech SE</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2023</amountOfSecuritiesAcquired>
      <paymentDate>08/09/2024</paymentDate>
      <natureOfPayment>Stock Option Exercise</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer.</remarks>
    <noticeSignature>
      <noticeDate>05/12/2026</noticeDate>
      <signature>/s/ Ugur Sahin</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
